Evaluation of Retinal Nerve Fiber Layer Thickness as a Possible Measure of 1 Diabetic Retinal Neurodegeneration in the EPIC-Norfolk Eye Study 2

[1]  N. Jansonius,et al.  U-shaped effect of blood pressure on structural OCT metrics and retinal blood flow autoregulation in ophthalmologically healthy subjects , 2021, medRxiv.

[2]  Jennifer K. Sun,et al.  Updating the Staging System for Diabetic Retinal Disease. , 2020, Ophthalmology.

[3]  L. Schmetterer,et al.  Association of Anti-hypertensive Medication with Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness. , 2020, Ophthalmology.

[4]  Hongbing Shen,et al.  Vitamin D status and risk of all-cause and cause-specific mortality in a large cohort: results from the UK Biobank. , 2020, The Journal of clinical endocrinology and metabolism.

[5]  B. Frankfort,et al.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies , 2019, Current Diabetes Reports.

[6]  Erdal Kurnaz,et al.  Quantitative evaluation of early retinal changes in children with type 1 diabetes mellitus without retinopathy , 2018, Clinical & experimental optometry.

[7]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. , 2018, Diabetes research and clinical practice.

[8]  T. Dryja,et al.  Systemic Medication Associations with Presumed Advanced or Uncontrolled Primary Open-Angle Glaucoma. , 2018, Ophthalmology.

[9]  Feng Wang,et al.  Alterations in retinal nerve fiber layer thickness in early stages of diabetic retinopathy and potential risk factors , 2018, Current eye research.

[10]  D. Y. Lee,et al.  Differential effects of blood insulin and HbA1c on cerebral amyloid burden and neurodegeneration in nondiabetic cognitively normal older adults , 2017, Neurobiology of Aging.

[11]  Ivan Maynart Tavares,et al.  The disc damage likelihood scale: Diagnostic accuracy and correlations with cup-to-disc ratio, structural tests and standard automated perimetry , 2017, PloS one.

[12]  Stephen J. Aldington,et al.  Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project , 2017, Diabetes.

[13]  M. Abràmoff,et al.  Diabetic retinopathy is a neurodegenerative disorder , 2017, Vision Research.

[14]  M. Glymour,et al.  High Hemoglobin A1c and Diabetes Predict Memory Decline in the Health and Retirement Study , 2017, Alzheimer disease and associated disorders.

[15]  Dina El-Fayoumi,et al.  Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses Are Reduced in Children With Type 1 Diabetes With No Evidence of Vascular Retinopathy. , 2016, Investigative ophthalmology & visual science.

[16]  Milan Sonka,et al.  Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus , 2016, Proceedings of the National Academy of Sciences.

[17]  P. Carpineto,et al.  Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus , 2016, Eye.

[18]  Xi Shen,et al.  Diabetic macular morphology changes may occur in the early stage of diabetes , 2016, BMC Ophthalmology.

[19]  F. Akay,et al.  Early Neurodegeneration of the Inner Retinal Layers in Type 1 Diabetes Mellitus , 2015, Ophthalmologica.

[20]  Harsha L Rao,et al.  Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography. , 2015, Investigative ophthalmology & visual science.

[21]  T. Wong,et al.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss , 2015, Eye and Vision.

[22]  A. Vicente,et al.  Retinal Layers Changes in Diabetic Patients without Diabetic Retinopathy , 2015 .

[23]  Milan Sonka,et al.  Relationships of retinal structure and humphrey 24-2 visual field thresholds in patients with glaucoma. , 2014, Investigative ophthalmology & visual science.

[24]  C. Rosano,et al.  Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications. , 2013, Journal of diabetes and its complications.

[25]  T. Gardner,et al.  Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications. , 2013, Current medicinal chemistry.

[26]  R. Luben,et al.  Associations with retinal nerve fiber layer measures in the EPIC-Norfolk Eye Study. , 2013, Investigative ophthalmology & visual science.

[27]  F. Horn,et al.  Glaucoma Diagnostic Performance of GDxVCC and Spectralis OCT on Eyes With Atypical Retardation Pattern , 2013, Journal of glaucoma.

[28]  M. Sonka,et al.  Early neurodegeneration in the retina of type 2 diabetic patients. , 2012, Investigative ophthalmology & visual science.

[29]  R. Raman,et al.  Does Neuronal Damage Precede Vascular Damage in Subjects with Type 2 Diabetes Mellitus and Having No Clinical Diabetic Retinopathy? , 2011, Ophthalmic Research.

[30]  Milan Sonka,et al.  Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. , 2010, Investigative ophthalmology & visual science.

[31]  R. Raman,et al.  Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and Spectral Domain Optical Coherence Tomography (SD-OCT) Study in individuals with diabetes, but no diabetic retinopathy , 2009, Eye.

[32]  J. B. Lopes de Faria,et al.  Diabetic Retinal Neurodegeneration Is Associated With Mitochondrial Oxidative Stress and Is Improved by an Angiotensin Receptor Blocker in a Model Combining Hypertension and Diabetes , 2009, Diabetes.

[33]  H. Quigley.  Can diabetes be good for glaucoma? Why can't we believe our own eyes (or data)? , 2009, Archives of ophthalmology.

[34]  David M Nathan,et al.  Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. , 2008, Archives of ophthalmology.

[35]  L. Katz.  Predictors of Long-term Progression in the Early Manifest Glaucoma Trial , 2008 .

[36]  A. Hofman,et al.  Systemic antihypertensive medication and incident open-angle glaucoma. , 2007, Ophthalmology.

[37]  R. Klein,et al.  The economic burden of major adult visual disorders in the United States. , 2006, Archives of ophthalmology.

[38]  Y. Greenman,et al.  Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors. , 2006, Journal of the cardiometabolic syndrome.

[39]  In Kyoon Lyoo,et al.  Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. , 2006, Diabetes.

[40]  S. Oh,et al.  Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome , 2005, Diabetes/metabolism research and reviews.

[41]  J. Hokanson,et al.  Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. , 2005, Diabetes care.

[42]  M. C. Leske,et al.  Hypertension, diabetes, and longitudinal changes in intraocular pressure. , 2003, Ophthalmology.

[43]  P. Mitchell,et al.  Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. , 1997, Ophthalmology.

[44]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.